Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Paroxetine I.P. 25mg Prolonged Release Tablets
Therapeutic Category
Antidepressant, Neurology, Sedative or Antianxiety
Dosage Form
Tablet
Packaging Type
Strip Pack
Packaging
10*10
Price
₹242/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Paroxyle 12.5 CR contains Paroxetine I.P. 12.5mg in a prolonged-release formulation. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that helps restore the balance of serotonin in the brain. By enhancing serotonin activity, Paroxyle 12.5 CR helps regulate mood, reduce anxiety, and alleviate symptoms associated with various mental health conditions. The prolonged-release (CR) formulation ensures a steady and gradual release of the drug, promoting longer-lasting effects and improving patient compliance. This medication is used primarily for treating mood disorders, anxiety, and obsessive-compulsive disorder (OCD).
Paroxyle 12.5 CR works effectively by preventing the reuptake of serotonin, a neurotransmitter responsible for regulating mood, sleep, and stress. By increasing serotonin levels in the brain, Paroxyle provides relief from symptoms of depression, anxiety, and obsessive thoughts. It is also helpful for those suffering from panic disorder and social anxiety. The controlled release helps maintain a stable concentration of the drug in the bloodstream, minimizing the risk of fluctuations that can lead to side effects.
Common side effects include nausea, dizziness, dry mouth, drowsiness, and sexual dysfunction. Serious side effects may include suicidal thoughts, serotonin syndrome, or allergic reactions. Contact a healthcare provider if any adverse effects occur.
Paroxyle 12.5 CR is indicated for the treatment of major depressive disorder, generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), panic disorder, and social anxiety disorder (SAD).
Take Paroxyle 12.5 CR exactly as prescribed by your healthcare provider. Avoid alcohol and follow the prescribed dosage.
Store in a cool, dry place away from sunlight and moisture. Keep out of reach of children.
Composition : Paroxetine I.P. 12.5mg Prolonged Release Tablets
Composition : Quetiapine Fumarate I.P. 100mg Tablet
Composition : Quetiapine Fumarate I.P. 25mg Tablet
Composition : Quetiapine Fumarate I.P. 50mg Tablet
Composition : Sertraline 100mg Tablet
Composition : Sertraline 25mg Tablet
Composition : Sertraline 50mg Tablet
Composition : Amisulpride 100mg Tablet
Composition : Amisulpride 200mg Tablet
Composition : Amisulpride (50mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Paroxetine Prolonged Release (PR) Tablets have strong demand in the psychiatry and CNS segment, making them a high-value maintenance product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for depression, anxiety disorders, panic disorder, and OCD, especially in patients requiring higher maintenance dosing and long-term therapy.
Medical distributors and agencies benefit from the consistent and long-term prescription flow in mental health treatments. Used as a maintenance or higher-dose therapy in depression and anxiety disorders Effective in panic disorder, generalized anxiety disorder, and OCD management Prolonged Release (PR) formulation improves tolerability and reduces side effects Widely prescribed by psychiatrists and general physicians Supports stable mood control and long-term compliance Ensures regular monthly repeat prescriptions due to chronic therapy This makes it a strong, stable, and high-retention CNS product.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Paroxetine 25 mg Prolonged Release Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from steady psychiatric prescription demand, strong chronic-care market penetration, repeat monthly sales, and long-term stability in the CNS and mental health segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete CNS product portfolio access to build a strong presence in the psychiatry and neurocare market.